Sibeprenlimab 400 mg s.c. Q4weeks clinical trials

Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)

This study looks at the long-term safety and effects of a medicine called sibeprenlimab for people with a kidney condition called IgA Nephropathy. It's for those who have already been part of earlier studies with this medicine.